 |
|
A clue to core problem of neurodegenerative disease and cell death
February 10, 2006Misfolded and damaged proteins are common to all human neurodegenerative diseases. Clumps of these aggregated proteins destroy neurons within the brain and cause disease. But explanations for the mechanism that actually causes cell death have varied widely, puzzling scientists and leading them to ask whether Alzheimer's, Parkinson's, Huntington's and Creutzfeldt-Jakob diseases and familial amyotrophic lateral sclerosis (ALS) are related diseases or very different diseases.
Northwestern University scientists now offer a clue that may get to the core of the cell death question and establish a common mechanism in these diseases. In a study to be published online Feb. 9 by the journal Science, the research team shows that polyglutamine (the toxic component of the protein responsible for Huntington's disease) is so demanding on the cell's system that it changes the environment within the cell, causing other metastable, or partially folded, proteins to crash and lose function. Over time, this can cause the organism to die.
"Our results suggest that these disease-associated, aggregation-prone proteins may exert their destabilizing effects by interfering generally with other proteins that are having difficulty folding," said Richard I. Morimoto, Bill and Gayle Cook Professor of Biochemistry, Molecular Biology and Cell Biology, who led the study. Morimoto is an expert in Huntington's disease and on the cellular and molecular response to damaged proteins.
"We found that the system for protein quality control is not robust at all - it is very delicate," said Morimoto. "Slight changes in the cell's environment have huge consequences. A single mutant polyglutamine protein interferes with the folding and functioning of very different types of proteins in the cell. This, in turn, could interfere with innumerable cellular processes and offers an explanation of why so many different mechanisms have been proposed for toxicity and cell death."
Morimoto speculates that it could be the misfolded protein's structure that, indirectly, is causing the other proteins to become non-functional. If so, these findings have implications for all neurodegenerative diseases. For each disease, a single or a small number of mutant proteins have been identified as causing the disease, and studies have shown that the misfolded states of these mutant proteins are all structurally related.
The experiments were conducted in C. elegans, a transparent roundworm whose biochemical environment is similar to that of human beings and whose genome, or complete genetic sequence, is known. The researchers picked seven random and unrelated proteins that are expressed in the same compartment in the cell as mutant polyglutamine. The seven metastable proteins - each essential to the functioning of muscle, nerve or hypodermal cells - had a temperature-sensitive mutation: the proteins are fine at normal temperature but when the temperature is elevated the mutation is expressed.
When the researchers introduced the toxic polyglutamine protein, the environment of the cell completely changed. In the case of each of the seven proteins, the presence of the expanded polyglutamine caused each mutation to be expressed at normal temperature. In turn, the metastable protein intensified the aggregation properties of the polyglutamine protein.
"These results could provide a very powerful tool for understanding all the neurodegenerative diseases," said Morimoto. "Do all proteins that cause this class of disease, such as mutant SOD in familial ALS or prions in Creutzfeldt-Jakob disease, have the same consequences? To find out, we plan to do the same experiments using the mutant proteins associated with the other diseases."
"This research suggests that a common mechanism may underlie a variety of protein folding diseases," said James Anderson, a geneticist at the National Institute of General Medical Sciences, at the National Institutes of Health, which partially funded the research. "While the hypothesis needs to be tested in other organisms, findings made in model organisms such as C. elegans are often the first step in understanding the molecular roots of human diseases."
Northwestern University
"We found that the system for protein quality control is not robust at all - it is very delicate," said Morimoto. "Slight changes in the cell's environment have huge consequences. A single mutant polyglutamine protein interferes with the folding and functioning of very different types of proteins in the cell. This, in turn, could interfere with innumerable cellular processes and offers an explanation of why so many different mechanisms have been proposed for toxicity and cell death."
Morimoto speculates that it could be the misfolded protein's structure that, indirectly, is causing the other proteins to become non-functional. If so, these findings have implications for all neurodegenerative diseases. For each disease, a single or a small number of mutant proteins have been identified as causing the disease, and studies have shown that the misfolded states of these mutant proteins are all structurally related.
The experiments were conducted in C. elegans, a transparent roundworm whose biochemical environment is similar to that of human beings and whose genome, or complete genetic sequence, is known. The researchers picked seven random and unrelated proteins that are expressed in the same compartment in the cell as mutant polyglutamine. The seven metastable proteins - each essential to the functioning of muscle, nerve or hypodermal cells - had a temperature-sensitive mutation: the proteins are fine at normal temperature but when the temperature is elevated the mutation is expressed.
When the researchers introduced the toxic polyglutamine protein, the environment of the cell completely changed. In the case of each of the seven proteins, the presence of the expanded polyglutamine caused each mutation to be expressed at normal temperature. In turn, the metastable protein intensified the aggregation properties of the polyglutamine protein.
"These results could provide a very powerful tool for understanding all the neurodegenerative diseases," said Morimoto. "Do all proteins that cause this class of disease, such as mutant SOD in familial ALS or prions in Creutzfeldt-Jakob disease, have the same consequences? To find out, we plan to do the same experiments using the mutant proteins associated with the other diseases."
"This research suggests that a common mechanism may underlie a variety of protein folding diseases," said James Anderson, a geneticist at the National Institute of General Medical Sciences, at the National Institutes of Health, which partially funded the research. "While the hypothesis needs to be tested in other organisms, findings made in model organisms such as C. elegans are often the first step in understanding the molecular roots of human diseases."
Northwestern University
Neurodegenerative Disease Current Events and Neurodegenerative Disease News RSSNovel mouse gene reduces major pathologies associated with Alzheimer's disease
A new study reveals that a previously undiscovered mouse gene reduces the two major pathological perturbations commonly associated with Alzheimer's disease (AD).
Mouse gene suppresses Alzheimer's plaques and tangles
Investigators at Burnham Institute for Medical Research (Burnham) and colleagues have identified a novel mouse gene (Rps23r1) that reduces the accumulation of two toxic proteins that are major players in Alzheimer's disease: amyloid beta and tau.
Widely used cholesterol-lowering drug may prevent progression
Simvastatin, a commonly used, cholesterol-lowering drug, may prevent Parkinson's disease from progressing further. Neurological researchers at Rush University Medical Center conducted a study examining the use of the FDA-approved medication in mice with Parkinson's disease and found that the drug successfully reverses the biochemical, cellular and anatomical changes caused by the disease.
Member of NFL Hall of Fame diagnosed with degenerative brain disease
The Center for the Study of Traumatic Encephalopathy (CSTE) at Boston University School of Medicine (BUSM) announced today that a recently deceased member of the NFL Hall of Fame suffered from the degenerative brain disease Chronic Traumatic Encephalopathy (CTE) when he died, becoming the 10th former NFL player diagnosed with the disease.
First former college football player diagnosed with CTE
The Center for the Study of Traumatic Encephalopathy (CSTE) at Boston University School of Medicine (BUSM) announced today that a deceased former college football player who died at age 42 was already suffering from the degenerative brain disease, Chronic Traumatic Encephalopathy (CTE).
Natural compounds, chemotherapeutic drugs may become partners in cancer therapy
Research in the Linus Pauling Institute at Oregon State University suggests that some natural food compounds, which previously have been studied for their ability to prevent cancer, may be able to play a more significant role in treating it - working side-by-side with the conventional drugs that are now used in chemotherapy.
August 10, 2009 New Class of Compounds Discovered for Potential Alzheimer's Disease Drug, Penn Study Finds
A new class of molecules capable of blocking the formation of specific protein clumps that are believed to contribute to the dementia of Alzheimer's disease (AD) patients has been discovered by researchers at the University of Pennsylvania School of Medicine.
Caffeine reverses memory impairment in Alzheimer's mice
Coffee drinkers may have another reason to pour that extra cup. When aged mice bred to develop symptoms of Alzheimer's disease were given caffeine - the equivalent of five cups of coffee a day - their memory impairment was reversed.
Huntington's disease deciphered
Researchers at the University of Illinois at Chicago College of Medicine have discovered how the mutated huntingtin gene acts on the nervous system to create the devastation of Huntington's disease.
What separates dangerous blood vessel plaques from benign ones
Researchers say they have evidence to explain what separates your average blood vessel plaque from those that are at high risk for triggering the development of dangerous-even fatal-blood clots.
More Neurodegenerative Disease Current Events and Neurodegenerative Disease News Articles
 |
Oxidative Stress in Cancer, AIDS, and Neurodegenerative Diseases (Oxidative Stress and Disease, 1) by Montagnier (Author) Presents basic, chemical, biological, and medical studies of free radicals on different targets and the consequences of their reactivity-covering the chemistry and biochemistry of free radicals, free radicals as second messengers that group the activation of transcription factors and enzymes, the importance of the antioxidant system in cell metabolism regulation, and the role of free radicals and antioxidants in disease management. Written by over 200 international authorities, the book offers incisive discussions on the significance of oxidant-antioxidant balance and cytotoxicity of free radicals when produced in excess by several sources, specifically radiation hydrogen peroxide as a stimulant of transcription factor NFkB leading to cell response against oxidative stress ... |
 |
Neurodegenerative Diseases: Neurobiology, Pathogenesis and Therapeutics by M. Flint Beal (Author), Anthony E. Lang (Author), Albert C. Ludolph (Author) Neurodegenerative diseases are major contributors to disability and disease, with Alzheimer's and Parkinson's diseases the most prevalent. This major reference reviews the rapidly advancing knowledge of pathogenesis and treatment of neurodegenerative diseases in the context of a comprehensive survey of each disease and its clinical features. The editors and contributors are among the leading experts in the field internationally. Covering basic science, diagnostic tools and therapeutic approaches, the book focuses on all aspects of neurodegenerative disease, including the normal aging process. The dementias, prion diseases, Parkinson's disease and atypical parkinsonisms, neurodegenerative ataxias, motor neuron diseases, degenerative diseases with chorea, iron and copper disorders, and... |
 |
Neurodegenerative Diseases and Metal Ions: Metal Ions in Life Sciences by Astrid Sigel (Editor), Helmut Sigel (Editor), Roland K. O. Sigel (Editor) About the Series... Metal Ions in Life Sciences links coordination chemistry and biochemistry in their widest sense and thus increases our understanding of the relationship between the chemistry of metals and life processes. The series reflects the interdisciplinary nature of Biological Inorganic Chemistry and coordinates the efforts of scientists in fields like biochemistry, inorganic chemistry, coordination chemistry, molecular and structural biology, enzymology, environmental chemistry, physiology, toxicology, biophysics, pharmacy, and medicine. Consequently, the volumes are an essential source for researchers active in these and related fields as well as teachers preparing courses, e.g., in Bioinorganic Chemistry. About this Book... Volume 1, devoted... |
 |
Fatal Attractions: Protein Aggregates in Neurodegenerative Disorders (Research and Perspectives in Alzheimer's Disease) by V.M.-Y. Lee (Editor), J.Q. Trojanowski (Editor), L. Buee (Editor), Y. Christen (Editor) In this volume are contributions based on a meeting arranged by the WHO and the Fondation IPSEN. The scientists focus on neurodegenerative disorders like Alzheimer's Disease, Chromosome 17-Linked Dementia, Parkinson's Disease and disorders with tauopathies. |
 |
So Much So Fast Starring: Stephen Heywood, Jamie Heywood Directed By: Steven Ascher;Jeanne Jordan What would you do if you were 29 and found you may only have a few years to live? So Much So Fast is about the remarkable events set in motion when Stephen Heywood discovers he has ALS (Lou Gehrig's disease) and his brother Jamie becomes obsessed with finding a cure. |
 |
Glutamine Repeats and Neurodegenerative Diseases: Molecular Aspects by Peter S. Harper (Editor), Max Perutz (Editor) (The Royal Society) Univ. of Wales, Cardiff, UK. Molecular biology text focuses on the discovery of a common pathogenic basis for a group of genetically inherited disorders, including Huntington's Disease. Discusses how these diseases share certain molecular similarities, what causes neurodegeneration to begin, and other important discoveries. For researchers and clinicians. |
 |
Molecular Mechanisms of Neurodegenerative Diseases (Contemporary Clinical Neuroscience) by Marie-Francoise Chesselet (Editor) Univ. of California, Los Angeles. First volume in this series. Synthesizes novel ideas and concepts emerging to create a fresh understanding of neurodegenerative disorders, details mechanistic similarities in Alzheimer's, Parkinson's, and related diseases. DNLM: Neurodegenerative Diseases--genetics. |
 |
Heat Shock Proteins and the Brain: Implications for Neurodegenerative Diseases and Neuroprotection (Heat Shock Proteins) by Alexzander A.A. Asea (Author), Alexzander A.A. Asea (Editor), Ian R. Brown (Editor) With the prevalence of neurodegenerative diseases on the rise as average life expectancy increases, the hunt for effective treatments and preventive measures for these disorders is a pressing challenge. Neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis have been termed 'protein misfolding disorders' that are characterized by the neural accumulation of protein aggregates. Manipulation of the cellular stress response involving the induction of heat shock proteins offers a therapeutic strategy to counter conformational changes in neural proteins that trigger pathogenic cascades resulting in neurodegenerative diseases. Heat shock proteins are protein repair agents that provide a line of defense against misfolded,... |
|
ADULTS WITH NEURODEGENERATIVE DISEASES: Occupational Therapy Practice Guidelines (Aota Practice Guidelines) by Susan Forwell (Author) | |
 |
Neurodegenerative Diseases: From Molecular Concepts to Therapeutic Targets by Rommy Von Bernhardi (Editor), Nibaldo C. Inestrosa (Editor) This book discusses in detail the different hypothesis and experimental evidence regarding the neurobiological mechanisms involved in neurodegenerative pathology, with an emphasis in Alzheimer's and Parkinson's disease. Since there are many hypotheses for neurodegenerative diseases, there is a real need for a comprehensive view, allowing for integration of the different views for the pathogenic mechanisms of the disease. |
| © 2009 BrightSurf.com |